Bacterial Pneumonia Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia
Condition: Community-acquired Bacterial PneumoniaInterventions: Drug: Solithromycin; Drug: MoxifloxacinSponsor: Cempra PharmaceuticalsRecruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 21, 2013 Category: Research Source Type: clinical trials
Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia
Condition: Community-acquired Bacterial PneumoniaInterventions: Drug: Solithromycin; Drug: MoxifloxacinSponsor: Cempra PharmaceuticalsRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 21, 2013 Category: Research Source Type: clinical trials
Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia
Condition: Community-acquired Bacterial PneumoniaInterventions: Drug: Solithromycin; Drug: MoxifloxacinSponsor: Cempra PharmaceuticalsRecruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 21, 2013 Category: Research Source Type: clinical trials
Bacterial Pneumonia Score (BPS) Guided Antibiotic Use in Children With Pneumonia and Pneumococcal Vaccine
Condition: Community Acquired PneumoniaInterventions: Behavioral: BPS; Behavioral: GuidelineSponsor: Hospital General de Niños Pedro de ElizaldeCompleted - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 10, 2013 Category: Research Source Type: clinical trials
Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia
Condition: Community-acquired Bacterial PneumoniaInterventions: Drug: Solithromycin; Drug: MoxifloxacinSponsor: Cempra PharmaceuticalsCompleted - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 24, 2012 Category: Research Source Type: clinical trials
